[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Diansan Su\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":76},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100620836","clinical-application-of-right-visual-double-lumen-tube-in-thoracoscopic-surgery-for-adult-patients-100620836",false,"NCT07362797","Clinical Application of Right Visual Double Lumen Tube in Thoracoscopic Surgery for Adult Patients","Comparison of Clinical Application of Right Visual Double Lumen Tube and Right Ordinary Double Lumen Tube in Thoracoscopic Surgery for Adult Patients","Inclusion Criteria:\n\n* Age: at least 18 years old, gender is not limited.\n* American Anesthesiologists Association (ASA) Grade I-III;\n* Elective Video-Assisted Thoracoscopic Lobectomy.\n* Informed consent of the patient or family member.\n* People who are willing to accept perioperative visits.\n\nExclusion Criteria:\n\n* Patients with contraindications for right double-lumen tube insertion (such as right bronchial tumor).\n* The patient has known tracheobronchial anatomical abnormalities\n* Patients previously diagnosed or suspected of having airway difficulty.\n* Patients who need rapid sequence induction.\n* Patients requiring emergency surgery\n* Patients who have undergone thoracic surgery, systemic infection or suspected tuberculosis in the past four weeks.","ALL","18 Years",{"count":19,"type":20},500,"ESTIMATED","INTERVENTIONAL",[23],"NA","This clinical trial aims to understand whether a visual double-lumen intubation tube can improve the first-attempt success rate and reduce complications compared to a standard double-lumen tube. The trial primarily aims to answer the following questions:\n\nDoes a double-lumen tube improve the first-attempt success rate?\n\nDoes a visual double-lumen tube reduce the likelihood of obstruction of the right upper lobe bronchial opening?\n\nDoes a visual double-lumen tube require fewer adjustments during surgery?\n\nDo patients with visual double-lumen tubes experience fewer perioperative complications compared to those with standard double-lumen tubes?\n\nParticipants will:\n\nUse a visual double-lumen tube partially and a standard double-lumen tube partially.\n\nRecord the perioperative status of all patients.",[26,27],"Thoracoscopic Surgery","Double Lumen Tube Intubation",[29,30,31,32],"double lumen tube","FOB","thoracoscopic surgery","Visual dual-lumen tube","NOT_YET_RECRUITING","2026-01-14",{"date":36,"type":37},"2026-01-23","ACTUAL",{"date":39,"type":20},"2025-12-30",{"date":41,"type":20},"2026-12-31",{"name":43,"class":44},"Diansan Su","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":52,"minAge":17,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":21,"phases":56,"briefSummary":57,"conditions":58,"keywords":62,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},"100618739","the-efficacy-of-remimazolam-on-incidence-of-hypoxia-during-sedated-transvaginal-oocyte-retrieval-a-multicenter-randomized-controlled-trial-100618739","NCT07335536","The Efficacy of Remimazolam on Incidence of Hypoxia During Sedated Transvaginal Oocyte Retrieval: A Multicenter Randomized Controlled Trial.","Inclusion Criteria:\n\n* Subjects aged 18 to 50 years planning to undergo painless oocyte retrieval\n* Subjects classified as American Society of Anesthesiologists (ASA) physical status I-II\n\nExclusion Criteria:\n\n* Subjects with contraindications to general anesthesia, acute or severe cardiovascular disease history, acute upper respiratory infection, chronic obstructive pulmonary disease (COPD), asthma attacks, or uncontrolled hypertension\n* Subjects with alcohol abuse\n* Subjects with severe hepatic or renal insufficiency, severe cardiovascular disease, or psychiatric disorder history\n* Subjects with hearing impairment preventing communication\n* Subjects with a history of long-term sedative or opioid use, or allergies to benzodiazepines, flumazenil, opioids and their antidotes, propofol, eggs, or soy products\n* Subjects with SpO2 \\\u003C 95% while breathing room air after entering the room","FEMALE","50 Years",{"count":55,"type":20},400,[23],"Hypoxia is the most common adverse reaction during sedation outside the operating room.Exploring novel drug combinations to reduce the incidence of hypoxia during sedation in patients undergoing transvaginal oocyte retrieval procedures enhances patient safety and lowers perioperative adverse event rates. This multicenter, prospective, randomized, controlled clinical study will compare the hypoxia incidence rate of the remimazolam-alfentanil combination against the commonly used propofol-alfentanil combination.",[59,60,61],"Hypoxia","Infertility","Infertility Assisted Reproductive Technology",[59,63,64,65],"oocyte retrieval","remimazolam","general anesthesia","RECRUITING","2026-01-01",{"date":69,"type":37},"2026-01-13",{"date":71,"type":37},"2025-10-20",{"date":73,"type":20},"2026-12-30",{"name":43,"class":44},3,""]